Your browser doesn't support javascript.
loading
Prognostic Model of Baseline Medications plus Neutrophil-to-lymphocyte Ratio in Patients with Advanced Non-small-cell Lung Cancer Receiving Immune Checkpoint Inhibitor plus Platinum Doublet: A Multicenter Retrospective Study.
Nasu, Izumi; Kondo, Masahiro; Uozumi, Ryuji; Takada, Shinya; Nawata, Shuichi; Iihara, Hirotoshi; Okumura, Yohei; Takemoto, Masashi; Mino, Kozo; Sasaki, Tadanori; Hirose, Chiemi; Aomori, Tohru; Shimano, Rena; Maeno, Ken; Oizumi, Satoshi; Kusumoto, Sojiro; Ohno, Yasushi; Ikemura, Shinnosuke; Takai, Daiya; Hara, Azusa; Kawazoe, Hitoshi; Nakamura, Tomonori.
Afiliação
  • Nasu I; Division of Pharmaceutical Care Sciences, Keio University Graduate School of Pharmaceutical Sciences, 1-5-30 Shibakoen, Minato-ku, Tokyo 105-8512, Japan.
  • Kondo M; Department of Pharmacy, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan.
  • Uozumi R; Department of Pharmacy, Nagoya City University Hospital, 1-Kawasumi, Mizuho-cho, Miskuho-ku, Nagoya, Aichi 467-8602, Japan.
  • Takada S; Department of Industrial Engineering and Economics, Tokyo Institute of Technology, 2-12-1 Ookayama, Meguro-ku, Tokyo 152-8552, Japan.
  • Nawata S; Department of Pharmacy, National Hospital Organization Hokkaido Cancer Center, 4-2-3-54, Kikusui, Shiroishi-ku, Sapporo 003-0804, Japan.
  • Iihara H; Department of Hospital Pharmaceutics, School of Pharmacy, Showa University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8666, Japan.
  • Okumura Y; Department of Pharmacy, Gifu University Hospital, 1-1 Yanagido, Gifu, Gifu 501-1194, Japan.
  • Takemoto M; Department of Pharmacy, Keio University Hospital, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
  • Mino K; Department of Pharmacy, Nagoya City University Hospital, 1-Kawasumi, Mizuho-cho, Miskuho-ku, Nagoya, Aichi 467-8602, Japan.
  • Sasaki T; Department of Pharmacy, National Hospital Organization Hokkaido Cancer Center, 4-2-3-54, Kikusui, Shiroishi-ku, Sapporo 003-0804, Japan.
  • Hirose C; Department of Hospital Pharmaceutics, School of Pharmacy, Showa University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8666, Japan.
  • Aomori T; Department of Pharmacy, Gifu University Hospital, 1-1 Yanagido, Gifu, Gifu 501-1194, Japan.
  • Shimano R; Department of Pharmacy, Keio University Hospital, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
  • Maeno K; Department of Pharmacy, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan.
  • Oizumi S; Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, 1-Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi 467-8602, Japan.
  • Kusumoto S; Department of Respiratory Medicine, National Hospital Organization Hokkaido Cancer Center, 4-2-3-54, Kikusui, Shiroishi-ku, Sapporo 003-0804, Japan.
  • Ohno Y; Respiratory Medicine and Allergology, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8666, Japan.
  • Ikemura S; Department of Cardiology and Respiratory Medicine, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu, Gifu 501-1194, Japan.
  • Takai D; Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
  • Hara A; Department of Respiratory Medicine, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan.
  • Kawazoe H; Division of Drug Development and Regulatory Science, Keio University Faculty of Pharmacy, 1-5-30 Shibakoen, Minato-ku, Tokyo 105-8512, Japan.
  • Nakamura T; Division of Pharmaceutical Care Sciences, Keio University Graduate School of Pharmaceutical Sciences, 1-5-30 Shibakoen, Minato-ku, Tokyo 105-8512, Japan.
J Cancer ; 14(5): 676-688, 2023.
Article em En | MEDLINE | ID: mdl-37056385

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article